AAAAAA

   
Results: 1-11 |
Results: 11
IN-VIVO INHIBITION OF AROMATIZATION BY EXEMESTANE, A NOVEL IRREVERSIBLE AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: GEISLER J KING N ANKER G ORNATI G DISALLE E LONNING PE DOWSETT M
Citation: J. Geisler et al., IN-VIVO INHIBITION OF AROMATIZATION BY EXEMESTANE, A NOVEL IRREVERSIBLE AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Clinical cancer research, 4(9), 1998, pp. 2089-2093
ACTIVITY OF EXEMESTANE, AN IRREVERSIBLE, ORAL, AROMATASE INHIBITOR INMETASTATIC POSTMENOPAUSAL BREAST-CANCER PATIENTS (MBC) FAILING TAMOXIFEN (TAM)
Authors: KVINNSLAND S ANKER G DIRIX LY BONNETERRE J PROVE AM WIKING N DEBELDER K MARIANI O DISALLE E MASSIMINI G
Citation: S. Kvinnsland et al., ACTIVITY OF EXEMESTANE, AN IRREVERSIBLE, ORAL, AROMATASE INHIBITOR INMETASTATIC POSTMENOPAUSAL BREAST-CANCER PATIENTS (MBC) FAILING TAMOXIFEN (TAM), European journal of cancer, 34, 1998, pp. 408-408
DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: BERGH J WIKLUND T ERIKSTEIN B FORNANDER T BENGTSSON NO MALMSTROM P KELLOKUMPULEHTINEN P ANKER G BENNMARKER H WILKING N
Citation: J. Bergh et al., DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS, Annals of oncology, 9(4), 1998, pp. 403-411
MEDICAL REPORT CONTENT RECOMMENDATIONS ON RECTAL-CARCINOMA - PART I -SURGICAL REPORT AND PATHOLOGICAL FINDINGS
Authors: ENGEL J STAIMMER D WIEBECKE B REIMER B ANKER G HOLZEL D RODER J JAUCH KW
Citation: J. Engel et al., MEDICAL REPORT CONTENT RECOMMENDATIONS ON RECTAL-CARCINOMA - PART I -SURGICAL REPORT AND PATHOLOGICAL FINDINGS, Zentralblatt fur Chirurgie, 123(10), 1998, pp. 1201-1204
EFFECTS OF HORMONES ON THE PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE
Authors: LIEN EA ANKER G LONNING PE REFSUM H UELAND PM
Citation: Ea. Lien et al., EFFECTS OF HORMONES ON THE PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE, Biochemical Society transactions, 25(1), 1997, pp. 33-35
DETECTION OF MICROMETASTASIS IN BONE-MARROW AND BLOOD IN HIGH-RISK STAGE-II BREAST-CANCER PATIENTS
Authors: KVALHEIM G GILEN E ERIKSTEIN B HERVIG I PHARO A WIST E SOMMER H ANKER G TELHAUG R NESLAND J
Citation: G. Kvalheim et al., DETECTION OF MICROMETASTASIS IN BONE-MARROW AND BLOOD IN HIGH-RISK STAGE-II BREAST-CANCER PATIENTS, Blood, 90(10), 1997, pp. 948-948
TREATMENT WITH FORMESTANE ALONE AND IN COMBINATION WITH AMINOGLUTETHIMIDE IN HEAVILY PRETREATED BREAST-CANCER PATIENTS - CLINICAL AND ENDOCRINE EFFECTS
Authors: GEISLER J JOHANNESSEN DC ANKER G LONNING PE
Citation: J. Geisler et al., TREATMENT WITH FORMESTANE ALONE AND IN COMBINATION WITH AMINOGLUTETHIMIDE IN HEAVILY PRETREATED BREAST-CANCER PATIENTS - CLINICAL AND ENDOCRINE EFFECTS, European journal of cancer, 32A(5), 1996, pp. 789-792
PHARMACOKINETICS OF TAMOXIFEN IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
Authors: LIEN EA ANKER G UELAND PM
Citation: Ea. Lien et al., PHARMACOKINETICS OF TAMOXIFEN IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 55(2), 1995, pp. 229-231
DETERMINATION OF DROLOXIFENE AND 2 METABOLITES IN SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY
Authors: LIEN EA ANKER G LONNING PE UELAND PM
Citation: Ea. Lien et al., DETERMINATION OF DROLOXIFENE AND 2 METABOLITES IN SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 17(3), 1995, pp. 259-265
ESTERIFICATION OF 12(S)-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID INTO THE PHOSPHOLIPIDS OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - INHIBITION OF THE PROLIFERATIVE RESPONSE
Authors: JOULAIN C MESKINI N ANKER G LAGARDE M PRIGENT AF
Citation: C. Joulain et al., ESTERIFICATION OF 12(S)-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID INTO THE PHOSPHOLIPIDS OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - INHIBITION OF THE PROLIFERATIVE RESPONSE, Journal of cellular physiology, 164(1), 1995, pp. 154-163
PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER TREATED WITH TAMOXIFEN
Authors: ANKER G LONNING PE UELAND PM REFSUM H LIEN EA
Citation: G. Anker et al., PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER TREATED WITH TAMOXIFEN, International journal of cancer, 60(3), 1995, pp. 365-368
Risultati: 1-11 |